Haemonetics Corporation (HAE)
Debt-to-equity ratio
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 820,836 | 959,959 | 817,997 | 749,424 | 731,670 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $820,836K
= 0.00
The debt-to-equity ratio for Haemonetics Corporation has been consistently reported as 0.00 from March 31, 2021, to March 31, 2024. However, the data for March 31, 2025, is denoted as "—". A debt-to-equity ratio of 0.00 generally indicates that the company has no debt or a negligible amount of debt in relation to its equity. This suggests that the company relies more on equity financing rather than debt financing, which can be seen as a positive sign, as it implies lower financial risk and a strong financial position. The missing data for March 31, 2025, warrants further investigation to evaluate any potential changes in the company's capital structure.
Peer comparison
Mar 31, 2025